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Abstract
Cigarette smoking continues to be a leading health problem in the United States and worldwide.
Despite high prevalence rates among some subpopulations of Asians and Asian Americans, little
attention has been focused on identifying effective smoking cessation interventions for this
group. A meta-analysis examining effect sizes was conducted to test the hypothesis that smoking
cessation interventions, overall, improve quit outcomes among Asians and Asian Americans.
Factors associated with intervention effectiveness were explored through moderator analyses.
Results show that overall, smoking cessation interventions are efficacious for Asians and Asian
Americans (OR = 2.33). Moderator analyses revealed high intensity treatments and treatments
with biochemical verification are associated with greater odds of cessation. Specific methods of
cultural tailoring were not found to have a significant effect on smoking cessation outcomes. The
present study has significant research, theoretical, and clinical implications for smoking
cessation interventions targeting Asians and Asian Americans.
Keywords: smoking cessation, smoking, intervention, Asians, Asian Americans, tobacco
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Exploring the Effectiveness of Smoking Cessation Interventions for Asians and Asian
Americans: A Meta-Analytic Review
Smoking remains a leading health problem in the United States. Although effective
empirically supported treatments are available, disparities in smoking prevalence remain among
different racial, ethnic, and cultural groups. However, little attention has been focused on
smoking cessation among Asians and Asian Americans (AAs). The current systematic review
and meta-analysis examined: 1) the effectiveness of smoking cessation interventions for AAs; 2)
whether culturally tailored smoking cessation interventions are more effective than nonculturally tailored smoking cessation interventions; and 3) moderating variables that strengthen
outcomes.
Smoking in the United States
In 2014, the Centers for Disease Control and Prevention (CDC) reported cigarette
smoking as the leading cause of preventable disease and death in the United States. In 2016, 37.8
million people identified as smokers in the United States; about 480,000 of these smokers will
die of smoking-related health problems (CDC, 2018; U.S. Department of Health and Human
Services (HHS), 2014). Mortality is three times higher for smokers than nonsmokers (HHS,
2014), and tobacco smoking is expected to lead to 450 million deaths worldwide in the next 50
years (CDC, 2005). Smoking is associated with many health consequences, such as increased
risk for cancer, chronic obstructive pulmonary disease (COPD), strokes, diabetes, and heart
disease (HHS, 2014).
Smoking in Asia
Male smoking prevalence in individual Asian countries is considerably higher than in the
United States (Benowitz et al., 1998). The breakdown of adult male current smoking rates for a
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few countries from 2016 are as follows: Korea (39.3%), Vietnam (45.3%), Philippines (40.3%),
Indonesia (64.9%), Laos (50.8%), Thailand (40.5%), India (24.3%), Tonga (42.1%) and China
(52.1%) (World Health Organization (WHO), 2017). China is the largest tobacco producer and
consumer in the world (WHO, 2013). In 2016, China and India had the highest death rates in the
world related to tobacco smoking and secondhand smoke exposure (Ritchie & Roser, 2018).
Smoking-Related Consequences among AAs
Although heart disease is the leading cause of death in the United States, lung and
bronchus cancer are the leading cause of death for AAs (Heron, 2007). Unhealthy behaviors like
smoking can contribute to cancer-related disparities. National studies estimate that AAs have the
lowest prevalence of smoking among major ethnic groups in the United States (Substance Abuse
and Mental Health Services Administration (SAMHSA), 2015). Current past-month cigarette
smoking rates for major ethnic groups in the United Sates are as follows: Asian Americans
(8.9%), Native Hawaiian/Pacific Islanders (18.3%), African Americans (21.4%), American
Indians/Alaska Natives (33.9%), Hispanics/Latinos (16.6%), Caucasian (15.2%) (CDC, 2018).
These estimates of smoking prevalence consider AAs in aggregate and often exclude some
populations. Additionally, these studies fail to consider education, language, immigration status,
age, socioeconomic status, and ethnic ancestry. For example, non-English-speaking populations
may not be represented due to the use of English only language surveys, which is an important
consideration since two-thirds of AAs are immigrants to the United States and 35% have low
English proficiency (Chae et al., 2006; Davis et al., 2017). Sources of disparity, such as
language, education, and immigration status, are important to examine as they may play a role in
AAs’ smoking (Zhang & Wang, 2008). A Chinese and Korean tobacco use survey reported
Cantonese-speaking Chinese men had higher current smoking rates than Chinese men in general
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(Carr et al., 2005). Additionally, the California Health Interview Survey found that 23.4% of
Asian males who do not speak English well or at all were current smokers, compared to 4% of
Asian males who do speak English well (UCLA Center for Health Policy Research, 2018).
Analysis of 2000 Census data by the Asian American Federation of New York Census
Information Center indicates that a large subset of New York Chinese smokers are foreign born
(75%), have limited English proficiency (63%), and do not have a high school diploma (42%)
(Asian American Federation of New York Census Information, 2004). These factors serve as
additional barriers to smoking cessation (Ja & Aoki, 1993).
Tobacco Interventions
Many effective tobacco interventions exist with aims to reduce smoking and smokingrelated health harms (Fiore, 2009). Tobacco interventions can be offered at the individual,
family, and community level. Existing tobacco interventions include pharmacological products,
behavioral counseling, self-help materials, and multicomponent interventions.
Pharmacological Interventions
Pharmacological cessation products include Nicotine Replacement Therapy (NRT) and
oral medications such as bupropion and varenicline. NRT include nicotine patches, nicotine gum,
nicotine nasal spray, nicotine inhaler, and nicotine lozenges. NRT works by delivering small
doses of nicotine to the body via skin absorption or membranes of the mouth (Stead et al., 2012).
NRT reduces withdrawal symptoms and cravings, increasing the likelihood of quitting (Stead et
al., 2012). Bupropion is a smoking cessation aid that acts as an antagonist at nicotinic receptors
to reduce cravings and withdrawal symptoms, while varenicline acts as an agonist to decrease
cravings and pleasurable effects of tobacco. Both medications are taken orally. Three metaanalyses reported NRT as an effective smoking cessation intervention (Etter & Stapleton, 2006;
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Hughes et al., 2003; Wu et al., 2006). Research has shown that bupropion and varenicline are
also effective smoking cessation interventions (Eisenberg et al., 2008; Wu et al., 2006). These
pharmacological interventions can reduce smoking substantially for AAs. The nicotine patch (Fu
et al., 2008: Ma et al., 2005; Wu et al., 2009) and varenicline (Nakamura et al., 2007; Tsai et al.,
2007) have preliminary evidence of short-term effectiveness among AAs. Ma et al. (2005) and
Wu et al. (2009) supplemented nicotine patches with brief behavioral counseling.
Health Education and Cognitive-Behavioral Counseling
Health education and cognitive-behavioral counseling have also been found to be
effective for smoking cessation. Health education and counseling consists of educating smokers
about health harms, ways to quit, and how to change smoking behaviors and cognition (Fang et
al., 2006). Counseling can be provided in an individual or group format. Meta-analyses
examining randomized control trials show counseling as an effective form of treatment for
smoking, with an odds ratio (OR) ranging from 1.20 to 1.64, which are modest effect sizes
(Lichtenstein et al., 1996; Mojica et al., 2004). Similar results were apparent for AA smokers. A
phone-counseling smoking cessation intervention showed effectiveness in a Chinese male
smoker population, with 53.3% of men abstaining from smoking at the time they completed the
program (Burton et al., 2010). Fang and colleagues (2006) found quit rates were higher for AA
smokers in the health counseling intervention than the control group (56.3% vs 31.8%).
Other forms of counseling include physician advice and utilization of quitlines.
Physicians often advise patients to quit smoking in order to improve their overall health.
Physician advice can be brief or part of a more intensive intervention. Stead et al. (2008)
conducted a meta-analysis examining physician advice and found a small effect size. Those
receiving physician advice had a higher rate of quitting than those not receiving physician advice
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(OR = 1.74). A national network of quitlines exist in which smokers can call a toll-free number
to receive telephone counseling (Fiore, 2009; North American Quitline Consortium (NAQC),
2009). Tobacco cessation quitlines can be offered in multiple languages and have been found to
be effective (Fiore, 2009; Lichtenstein et al., 2010; Zhu et al., 2002). Zhu et al. (2010) conclude
that AAs are utilizing the quitline, with similar rates of successful smoking cessation (Zhu et al.,
2012).
Self-Help Interventions
Self-help interventions are usually comprised of educational materials, and cessation and
maintenance manuals (e.g., books, videos). Self-help materials can reach a large number of
smokers, are cost effective and do not require attendance (Davis et al., 1984; Prochaska et al.,
1993). Although cost effective, self-help interventions are less effective compared to other
interventions (Davis et al., 1984). At this time, no published studies have examined the use of
self-help materials in AAs.
Multicomponent Interventions
Multicomponent interventions consist of two or more different types of interventions.
Quitlines offer over the phone counseling in addition to other services such as providing
educational material and NRT material (Fiore, 2009). Often, NRT is paired with behavioral
counseling, which has shown to be effective by increasing quit rates by two-fold (Mojica et al.,
2004). However, most multicomponent interventions have a primary treatment, with
supplemental treatments. If a primary treatment is apparent, it will be treated as a single
component treatment.
Other Intervention Methods
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Other smoking cessation interventions include media campaigns, community outreach,
hypnosis, and acupuncture (Fiore et al., 2009). Currently there is insufficient evidence to support
hypnosis and acupuncture as effective smoking cessation interventions (Fiore et al., 2009).
Community outreach involves effort from the community to provide services to populations who
have barriers to services or limited resources.
Rationale for Systematic Review and Meta-Analysis
Overall Effectiveness of Smoking Cessation Interventions Among AAs Across Studies is
Unknown.
Although there is much evidence supporting the effectiveness of the aforementioned
smoking cessation interventions in the general population, there is less work that has been done
within the AA population specifically. There are few studies that tested various interventions for
smoking cessation within AAs specifically, but, to our knowledge, there have been no systematic
reviews to determine the overall effectiveness of these interventions for AAs. Although these
interventions differ from each other in many ways, these interventions also share similarities that
warrant the use of meta-analytic methods (Webb, 2008). First, the research goals are similar,
aiming for smoking cessation in each study. Second, many of the studies are multicomponent
(Ma et al., 2005; Prochaska et al., 1993; Wu et al., 2009). Third, these studies include
participants who share similar cultural worldviews. Fourth, there is overlap in the designs of the
studies. Many studies are longitudinal, include follow up, and have similar statistical design.
Lastly, other scholars have conducted meta-analyses to determine the effectiveness of smoking
cessation interventions in the general population (Baillie et al., 1994) as well as ethnic
populations (e.g., African Americans, Latinos) (Webb, 2008; Webb et al., 2010). AAs are often
excluded from recent studies and trials due to language barriers and many studies do not report
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on the breakdown of ethnicity; therefore, it is important to review smoking cessation among
them (Chae et al., 2006). Although there is great diversity among AAs, they also share numerous
similarities. According to Kim et al. (2001), AAs have been found to share similar cultural
values of collectivism, conformity to norms, emotional self-control, family recognition through
achievement, filial piety, and humility. These shared cultural values may be due to these cultures
being heavily rooted in the Buddhist and Confucian philosophies (Kim et al., 2001). In most AA
cultures, men are reported to smoke more than women, and demonstrate the largest gap in
smoking rates between genders, with 17.5% males and only 6.5% females smoking (CDC,
2005).
Differences in Effectiveness Across Tailored vs Non-tailored Interventions is Unknown.
Cultural responsiveness advocates argue that interventions are more effective when
consistent with a population’s cultural norms, beliefs, and other characteristics unique to the
group (e.g., American Psychological Association, 2003; Baldwin, et al., 1996; Barrera Jr. et al.,
2013; Bernal et al., 2009; Resnicow et al., 2000; Sue et al., 1991; Vega, 1992). Smoking
cessation interventions can be and have been culturally tailored for AA populations. A metaanalysis conducted by Huey and Tilley (2018) found that mental health treatments adapted for
Asian American subgroups showed the largest effects when compared to non-culturally tailored
treatments. Cultural tailoring can include surface structure, which involves matching intervention
materials to characteristics of a population, such as changing the language or translation of
materials, ensuring race matched interventionists, using race relevant epidemiological data and
testimonials, and editing material to match AA history or images (Bernal et al., 1995; Bernal et
al., 2009; Resnicow et al., 2000; Webb, 2008). Cultural tailoring can also include deep structure,
which involves incorporating cultural, social, historical, environmental, and psychological forces
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that influence the health behavior in the population, such as considering peer or family influence,
migration, and acculturational stress (Resnicow et al., 2000). It is important to note how
interventions take into account smokers’ cultural backgrounds and whether culturally tailored
smoking cessation interventions are more effective for the AA population.
Rationale for Exploring Moderators
Smoking cessation interventions often differ in many ways, so it is important to examine
different factors that may be associated with smoking cessation outcomes. Treatment intensity is
the “dose” of intervention and varies across interventions. Low intensity treatments, such as selfhelp materials, are often more cost effective and easily disseminated, but tend to be less
effective. Low intensity treatments are useful for reaching a greater population, especially
underserved smokers who have less resources or would not seek assistance otherwise (Webb,
2008). High intensity treatments require more effort and engagement, such as visiting a clinic
multiple times and frequent contact with health providers. High intensity treatments tend to yield
better outcomes regarding smoking cessation, although they are often costly and difficult (Fiore
et al., 2000). Treatment duration also varies from study to study and can play a role in the
intensity of the treatment. However, longer treatment duration does not always equate to greater
intensity. Overall, intense interventions tend to yield larger effects due to the robust doseresponse relationship between treatment intensity and outcome (Fiore et al., 2000), therefore,
treatment intensity should be considered a moderator.
Interventions for specific racial and ethnic groups often have some cultural adaptations.
Culturally specific interventions consider culture throughout the development, implementation,
and evaluation process. Researchers consider cultural values, beliefs, traditions, and
characteristics that are specific to the racial/ethnic group. Cultural tailoring can include using
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pictures and testimonials from other AAs, translating material into the group’s primary language,
and providing race matched interventionists (Harris et al., 2001; Kreuter et al., 2003). Clinical
practice guidelines state support for cultural tailoring remains inconclusive (Fiore et al., 2008).
However, research suggests that culturally tailored interventions yield greater effects (Fiore et
al., 2000), therefore, cultural tailoring should be considered a potential moderator.
The term “smoking cessation” is operationalized differently in many studies. Research in
this area has operationalized smoking cessation as no smoking at the time of assessment, point
prevalence, prolonged abstinence, and continuous abstinence (Velicer et al., 1992). These
measurements can also differ in time points (e.g., seven days, six months, etc). Additionally,
smoking status can be self-reported or biologically validated via expired breath carbon
monoxide, saliva/urine cotinine, or both. Biochemical verification is often preferred to reduce
social desirability bias, response bias, and recall bias. Biochemical verification can increase
smoking cessation as it holds smokers accountable compared to self-report; therefore, it could be
a potential moderator.
Flay and Petraitis’ (1994) Theory of Triadic Influence (TTI) is useful to better understand
tobacco use (Flay & Petraitis, 1993). The TTI proposes that tobacco use can be influenced by
three streams of influences: cultural environmental, intrapersonal, and social (Flay et al., 2009).
Cultural environmental influences refer to “multiple sociocultural macro- environmental factors
that contribute to attitudes toward specific behaviors” (Flay et al., 2009, p. 453). These macroenvironmental factors include immediate surroundings such as local crime and employment
rates, poor career and academic options, media depictions of cigarette smoking, and culture.
Other factors include knowledge, expectancies, and attitudes toward cigarette smoking. Social
influences refer to “the social situation/context or microenvironment that contribute to social
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normative beliefs about specific behaviors” (Flay et al., 2009, p. 453). Social influences include
relationships with peers, parents, and immediate and extended family members. Therefore, it is
important to consider how culture and acculturation may affect smoking cessation outcomes.
The Theory of Planned Behavior can be used to understand health behavior; more
specifically, it suggests that the likelihood of an individual engaging in a health behavior is
correlated with his or her intention to engage in the behavior (Ajzen, 1991). Therefore, there is
reason to believe that those who have intent to quit are more likely to successfully quit smoking.
Breslau and Johnson (2000) found that the Fagerstrom Test for Nicotine Dependence
(FTND)-defined nicotine dependence predicted smoking cessation, with nondependent smokers
four times more likely to quit smoking than dependent smokers. Not only that, the Diagnostic
and Statistical Manual Third Edition - Revised (DSM-III-R) defined nicotine dependence also
predicted cessation, with similar results (Breslau & Johnson, 2000). This indicates that nicotine
dependency could have an effect on smoking cessation outcomes.
Current Study
Despite high smoking rates, the majority of AA smokers want to quit (Babb et al., 2017).
Therefore, it is important to examine smoking cessation interventions to assist AAs with
successful quitting, as smokers who use assistance have higher quit rates than those who do not
(Zhu et al., 2000). To our knowledge, the current review is the first meta-analytic examination of
smoking cessation interventions among AA adults. Meta-analyses typically examine a
combination of studies that are diverse in approach and methodology, therefore heterogeneity in
effect sizes is possible (Higgins et al., 2002). Using meta-analytic technique allows a cohesive
picture of the phenomenon to be captured (Cooper, 2009). Meta-analytic procedures are useful
for comparing study findings by study characteristics, such that sources of systematic differences
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across studies can be identified. Because meta-analyses include multiple samples, analyses are
more reliable and generalizable (Cohn & Becker, 2003; Cooper, 2009). The main objectives of
this review were to: (1) evaluate the effectiveness of smoking cessation interventions compared
with control groups; (2) evaluate the effectiveness of culturally tailored smoking cessation
interventions compared with non-culturally tailored smoking cessation interventions; and (3)
investigate moderator variables (e.g., acculturation, intentions to quit, cultural tailoring, nicotine
dependence, treatment intensity and duration, component type) that may play a role in the
relationship between treatment groups and smoking cessation. Results from this meta-analytic
review will provide researchers, healthcare providers, and smokers with information on the most
effective interventions to increase smoking abstinence among AAs.
Hypotheses
1. Smoking cessation interventions for AAs would be more effective relative to control
conditions (Burton et al., 2010; Fang et al., 2006; Fiore et al., 2009; Fu et al., 2008: Ma et
al., 2005; Wu et al., 2009).
2. Multicomponent interventions would have larger treatment effects than single component
interventions (Fiore, 2009).
3. Culturally tailored interventions would have larger treatment effects than non-culturally
tailored interventions (Bernal et al., 2009; Huey & Tilley, 2018; Sue et al., 1991; Vega,
1992).
4. Interventions culturally tailored for AA subgroups would have larger treatment effects
than interventions culturally tailored for AA broadly (Huey & Tilley, 2018).
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5. It was expected that certain participant and treatment variables would moderate the
relationship between treatment and smoking cessation outcomes. It was hypothesized that
treatment effects would be:
a. Smaller for smokers with higher nicotine dependence (Fiore, 2009).
b. Larger for treatments with greater treatment intensity (Fiore, 2009).
c. Larger for treatments with longer treatment duration (Fiore, 2009).
d. Larger for smokers with stronger intention to quit (Fiore, 2009).
e. Larger for smokers with higher acculturation (Zhang & Wang, 2008).
Method
Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA)
guidelines are used to guide the reporting systematic reviews and meta-analyses of health care
interventions (Liberati et al., 2009). The current study followed PRISMA guidelines, which
include a 27-item checklist (Appendix A) and a four-phase information flow diagram (Figure 1).
The PRISMA statement was used to assist with the appraisal of the literature, report findings,
and to decrease report bias of systematic reviews and meta-analyses (Moher et al., 2009). The
current study is registered in the Open Science Framework.
Literature Search
All articles were identified using these seven major databases: PsycINFO, PubMed,
Cumulative Index to Nursing and Allied Health Literature (CINAHL), ScienceDirect, Google
Scholar, Health Source: Nursing/Academic Edition, and Cochrane Central Register of Controlled
Trials (CENTRAL). Additionally, articles were found through the examination of reference lists
in past research as well as the review of pertinent journals in the field (e.g., Health Psychology).
Clinical trial databases (e.g., clinicaltrials.gov), dissertation and thesis databases (e.g.,
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Dissertation Direct), and unpublished manuscripts were also reviewed to minimize selection
bias. Researchers were identified and emailed to ask for any unpublished research and
manuscripts. The PICO (patient/problem, intervention, comparison, outcome) strategy was used
to guide the development of search terms (Santos et al., 2007). The problem identified is
smoking in the population of AAs. The interventions being evaluated are smoking cessation
interventions. The treatment group is compared to a control group (no treatment, waitlist,
standard treatment). The outcome of interest is success or failure to quit smoking at time one
post intervention. Searches were conducted using Boolean operators (OR/AND) with a variation
of these terms: “Asian,” “Asian American,” “smoking,” “tobacco,” “tobacco dependence,”
“cigarettes,” “interventions,” “programs,” “cessation,” and other related search terms.
Furthermore, these search terms were used in combination with specified ethnicities, such as
“Chinese,” “Chinese American,” and “Vietnamese.” See Appendix B for more search terms.
Inclusion Criteria
Inclusion criteria included: (1) studies examining and/or evaluating interventions that aim
to reduce smoking; (2) interventions targeting AA smokers or with an overrepresentation of AAs
(i.e., about 50% of the sample); (3) adult participants (over age 17); (4) randomized controlled
trials (RCTs) that provides quantitative outcomes; and (5) studies written in English.
Exclusion criteria
Exclusion criteria included: (1) interventions targeting nonsmokers; (2) interventions
targeting non-AA smokers; (3) interventions including AA smokers younger than 18; (4)
interventions targeting health behaviors other than smoking; (5) studies that are not written in
English; (6) studies that are not RCTs and do not provide quantitative outcomes; and (7) metaanalyses and literature reviews.
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Article Selection and Coding Procedures
Article screening and selection was conducted in March 2019. Article selection and data
extraction started with the principal investigator screening articles based on titles, abstracts, and
full text. Eligible articles were then screened by a team of researchers. Researchers
independently screened articles based on the full text. A second researcher screened and verified
20% of the eligible references to minimize bias (Soilemezi & Linceviciute, 2018).
Disagreements on the eligibility of articles were discussed during consensus meetings until
consensus was reached.
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Figure 1

Eligibility

Screening

Identification

Flow of Information as Recommended by PRISMA.

2793 articles identified through
database search

421 total articles identified

249 duplicates removed

172 titles/abstracts
screened

102 records excluded

70 full text articles
assessed for eligibility

41 records excluded,
with reasons

29 studies included in
qualitative synthesis

Included

5 articles identified through other
sources

28 studies included in
quantitative synthesis
(meta-analysis)
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A coding manual and data extraction forms were created a priori and used to extract
relevant information including: (1) the citation; (2) article characteristics (e.g., publication year);
(3) study design; (4) sample; (5) predictor variables (e.g., treatment type, treatment intensity,
treatment setting, treatment duration); (6) outcomes measured (e.g., smoking status, effect size);
(7) unit of analysis; (8) cultural tailoring that were made primarily for AA smokers (e.g.,
language, translation of materials); (9) risk of bias (e.g., research design, how outcome is
measured (self-report vs. biochemical verification)); and (10) coder characteristics (e.g., date
coded) (Cooper, 2015; Higgins et al., 2011). Regarding cultural tailoring, we coded whether the
intervention was tailored specifically for AA subgroups (e.g., inclusion of Chinese Americanspecific norms and beliefs), tailored broadly for AA (e.g., use of AA cultural values such as the
importance of familial support), tailored broadly for ethnic/cultural minorities (e.g., reframed
Western concepts of smoking), or not culturally tailored at all (Huey & Tilley, 2018). When
effect sizes could not be calculated due to missing information, attempts were made to contact
the author(s) of the article to obtain the information needed to calculate the effect size. Only
studies with calculable effect sizes for AAs were included in this meta-analysis. When more than
one study implemented the same intervention, but with a different sample, both studies were
included and examined. The data screening and extraction form is presented in Appendix C.
Researchers used Microsoft Excel Online to code articles. Microsoft Excel Online allows
coders to code simultaneously and be updated live online. A pilot test was conducted before
initiating official coding by the team of trained researchers to ensure clarity of variables. Two
studies were randomly selected and coded by researchers. Discrepancies were discussed and the
coding manual was revised based on coders’ feedback in order to have a shared understanding of
the items in the manual and consistency among coders in using the manual. Articles were evenly
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and randomly distributed to coders. Coder reliability was established by having 20% of the
identified articles double coded by a second coder (Wilson et al., 2003). These reliability checks
occurred throughout the coding process to ensure major discrepancies were resolved.
Statistical Analyses
Twenty-eight studies representing a sample of 17,660 participants were included in the
analysis. Main effect sizes for each study were calculated in terms of the odds ratio (ESOR). The
ESOR compared treatment and control groups on the relative odds of smoking cessation using a
random effects model, which assumes that effect sizes vary for each study used in the metaanalysis, and allows for greater generalization of findings (Cooper, 2015). ESOR of 1.0 were
interpreted as no relationship. ESOR less than 1.0 were interpreted as a negative relationship (the
odds of cessation are greater in the control condition) and ESOR greater than 1.0 were interpreted
as a positive relationship (the odds of cessation are greater in the intervention condition)
(Cooper, 2015). ORs were calculated using the Comprehensive Meta-Analysis (CMA) (Version
3.0) software. ORs are based on the non-normal chi-square distribution, therefore analyses were
conducted on the logged-OR, which is an approximately normal distribution. All effect size
estimates are reported with 95% confidence intervals (CIs). CIs that do not include 1.0 are
considered statistically significant at the p < .05 level.
First, ESOR were computed for each study. All studies reported proportions of smoking
cessation, which were entered into a 2x2 table (Figure 2), with rows indicating the number of
participants who successfully quit smoking and those who did not, and columns representing the
number of participants who received the intervention and those who did not. Participants who
dropped out of the intervention were assumed to have not quit smoking. Cell frequencies were
then converted into ESOR using the following formula: ESOR = ad/bc, where a and b refer to the
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number of participants with successful smoking cessation in the treatment and control groups,
respectively; and c and d are the number of participants with unsuccessful cessation in the
intervention and control groups, respectively (Cooper, 2015).
Figure 2
Proportions of Smoking Cessation

Quit (n)
Not Quit (n)
Odds ratio: ________

Intervention (n)
a
c
>1  (intervention) 0  (no relationship)

Control (n)
b
d
<1  (control)

Second, ESOR were transformed into logged odds ratios using CMA to correct for
potential sample size bias. The logged odds-ratios were converted back into general odds ratios
to compute descriptive statistics and CIs. Homogeneity tests were conducted based on
the Q statistic developed by Hedges and Olkin (1985). The power to detect heterogeneity within
a small number of studies can be low, therefore the I2 statistic, an alternative to Q, was used to
estimate the degree of inconsistency in studies’ outcomes (Higgins & Thompson, 2002).
Third, after effect sizes for each study were calculated, an average effect size, combining
all studies, was calculated using CMA. The average effect size was weighted based on the
number of participants in each sample. To calculate the average effect size, each effect size was
multiplied by the sample size. Then the sum of these products was divided by the sum of the
sample sizes (Cooper, 2015).
Fourth, after analysis of overall effect size, moderator analyses were conducted to address
sample and study characteristics that may alter the effect size. Moderators were analyzed if Q
was significant, if moderators were characteristic of at least 10 studies (Borenstein et al., 2009),
and if there was significant unexplained variability in effect sizes (Lipsey & Wilson, 2001).
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Categorical variables were tested using meta-regression models in SPSS Statistics, Version 25, to
test multiple moderators sequentially. Categorical moderator variables (such as “culturally
tailored” vs. “not culturally tailored”) were given binary codes (0 or 1). Meta-regression is
similar to multiple regression in which effect sizes are evaluated as criterion variables and study
characteristics are the predictors (Cooper, 2015; Hartung et al., 2008; Shelby & Vaske, 2008).
Lastly, a forest plot was created to illustrate the distribution of ESOR and the CIs around
the individual effect sizes. The forest plot also identifies any outliers that should be considered
when interpreting the overall results.
Results
Sample Description
Characteristics of the individual studies included in the analysis and coding information
are described in Table 1. All studies were RCTs. The sample size across studies ranged from 30
to 1860 participants (M = 630.71, SD = 510.78), the mean ages ranged from 20.7 to 58.3 years
old (M = 43.42, SD = 7.26), and male percentage ranged from 60% to 100% (M = 88.08, SD =
10.18). Of the overall sample, 88% were males. Ethnicity breakdown is as follows: 72%
Chinese, 17% Korean, 10% Japanese, 1% Thai.
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Table 1
Characteristics of Individual Studies included in Meta-Analysis
Study

ID

N

OR

DOE

TYPE

COM

CUL

LOC

INT

DUR

OUT

BIO

Abdullah et al.
(2005)
Chan et al. (2008)

1

952

2.26

+

3

1

4

1

2

5

3

1

15

1483

1.60

+

6

1

4

1

2

2

3

1

Chan et al. (2010)

12

719

4.83

+

3

1

4

1

3

3

3

0

Chan et al. (2011)

13

1154

1.87

+

3

1

4

1

3

4

3

0

Chan et al. (2012)

14

1860

1.06

+

3

0

4

1

2

3

3

1

Fagerstrom et al.
(2010)
Fang et al. (2006)

20

893

2.71

+

5

1

4

1

3

4

4

0

21

66

2.37

+

1

1

1

0

2

1

3

1

Gu (2015)

23

900

25.63

+

3

1

4

1

3

3

–

–

Ito et al. (2006)

27

697

0.82

-

7

1

4

1

1

6

–

1

Kim et al. (2005)

32

401

2.13

+

3

0

4

1

2

–

2

0

Kim et al. (2012)

33

30

4.00

+

3

1

2

0

3

4

3

0

Kim et al. (2015)

36

109

4.94

+

3

1

2

0

3

4

6

0

Lam et al. (2012)

40

1154

3.36

+

3

1

4

1

3

5

3

0

Liao et al. (2018)

63

1369

3.43

+

7

0

4

1

3

5

5

0

McDonnell et al.
(2011)
Moskowitz et al.
(2016)
Nakamura et al.
(2007)
Nakamura et al.
(2017)
Paek et al. (2014)

47

1409

0.85

-

7

0

2

0

2

–

4

1

49

403

1.11

+

7

0

2

0

2

5

4

1

51

618

2.16

+

5

1

4

1

3

4

4

0

50

210

2.19

+

5

0

4

1

2

5

–

0

54

332

1.63

+

7

0

4

1

2

5

4

0

Sheng et al. (2012)

60

257

3.71

+

2

1

4

1

3

4

4

0

Sun et al. (2009)

61

211

4.68

+

1

1

4

1

3

4

–

0

Tong et al. (2018)

65

205

0.77

-

6

1

2

0

3

4

4

0

Tsai et al. (2007)

67

250

3.09

+

5

1

4

1

3

4

4

0

Wang et al. (2017)

53

1077

1.49

+

4

1

4

1

2

5

3

0

White et al. (2013)

41

201

1.78

+

3

1

4

1

1

–

3

0

Wu et al. (2005)

18

139

4.20

+

3

1

2

0

3

5

5

0

Wu et al. (2017)

10

369

2.09

+

4

1

4

1

1

6

5

1

Yang et al. (2018)

52

192

6.64

+

3

0

4

1

3

3

–

0

Note. – = missing data; N = number of participants in the analysis; OR = odds ratio; DOE = direction of effect (+ = treatment; - = control); TYPE
= primary treatment type (1 = nicotine replacement; 2 = bupropion; 3 = individual counseling; 4 = physician advice; 5 = varenicline; 6 = health
education; 7 = other); COM = component (0 = single; 1 = multiple); CUL = cultural tailoring (1 = AAs broadly; 2 = AA subgroups; 3 =
ethnic/cultural minorities broadly; 4 = no cultural tailoring); LOC = location of intervention (0 = United States; 1 = Asian country); INT =
treatment intensity (1 = low; 2 = moderate; 3 = high); DUR = treatment duration (1 = within a day; 2 = within a week; 3 = within a month; 4 =
within 3 months; 5 = within 6 months; 6 = within 12 months); OUT = outcome measure (1 = no smoking at the time of the assessment/when
interviewed; 2 = 24-hour point prevalence abstinence (no smoking for past 24 hours); 3 = 7-day point prevalence abstinence; 4 = 1 month (28day) continuous abstinence; 5 = 6 month sustained abstinence; 6 = 12 month sustained abstinence); BIO = biochemical verification (0 = yes; 1 =
no).
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General Effects
The meta-analysis assessing smoking cessation effectiveness produced an average OR of
2.33 (95% CI = 1.77 to 3.06, n = 28), which is a small to medium effect size. This statistic
indicates greater odds of smoking cessation in the treatment conditions compared to the control
conditions. Figure 3 is a forest plot representing the effect sizes of each individual study included
in the analysis. The homogeneity tests were significant, indicating variability in effect sizes (p =
.00, I2 = 86.48) due to factors other than sampling and treatment error. Overall, results suggest
that smoking cessation interventions were more effective than control conditions for AAs.
Figure 3
Forest Plot of Effect Sizes of Studies

Meta Analysis
Study name

Statistics for each study
Odds
ratio

Abdullah et al. (2005) 2.261
Chan et al. (2008)
1.600
Chan et al. (2010)
4.829
Chan et al. (2011)
1.872
Chan et al. (2012)
1.056
Fagerström et al. (2010) 2.712
Fang et al. (2006)
2.368
Gu (2015)
25.632
Ito et al. (2006)
0.823
Kim et al. (2005)
2.126
Kim et al. (2012)
4.000
Kim et al. (2015)
4.941
Lam et al. (2012)
3.362
Liao et al. (2018)
3.426
McDonnell et al. (2011) 0.849
Moskowitz et al. (2016) 1.107
Nakamura et al. (2007) 2.160
Nakamura et al. (2017) 2.185
Paek et al. (2014)
1.627
Sheng et al. (2012)
3.707
Sun et al. (2009)
4.680
Tong et al. (2018)
0.769
Tsai et al. (2007)
3.088
Wang et al. (2017)
1.488
White et al. (2013)
1.776
Wu et al. (2005)
4.200
Wu et al. (2017)
2.088
Yang et al. (2018)
6.641
2.329

Lower
limit

Upper
limit

1.466
1.035
2.600
0.951
0.859
2.068
0.830
14.560
0.507
1.258
0.849
1.803
1.735
1.624
0.588
0.548
1.438
1.078
1.052
1.856
2.529
0.379
1.840
0.964
0.944
1.972
0.943
0.338
1.771

3.486
2.472
8.971
3.683
1.300
3.558
6.755
45.124
1.336
3.591
18.836
13.540
6.515
7.226
1.224
2.237
3.245
4.427
2.516
7.402
8.658
1.558
5.184
2.295
3.341
8.946
4.622
130.331
3.064

Odds ratio and 95% CI

Z-Value

p-Value

3.691
2.117
4.984
1.815
0.520
7.206
1.612
11.242
-0.787
2.818
1.754
3.106
3.594
3.234
-0.877
0.283
3.710
2.168
2.190
3.713
4.916
-0.730
4.267
1.796
1.780
3.720
1.815
1.247
6.042

0.000
0.034
0.000
0.070
0.603
0.000
0.107
0.000
0.431
0.005
0.080
0.002
0.000
0.001
0.381
0.777
0.000
0.030
0.029
0.000
0.000
0.465
0.000
0.072
0.075
0.000
0.069
0.213
0.000
0.01

0.1
Favours A

1

10
Favours B

Meta Analysis

Note. The squares represent the odd ratios value. CI = confidence interval.
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Demographics
Average age for each study was divided into four groups (21-30 years old, 31-40 years
old, 41-50 years old, and 51-60 years old). A permutation test indicated there were no significant
differences between age groups ( = 6.43, df = 3, p = 0.09). A Kruskal-Wallis rank sum test
confirmed this conclusion,  = 6.01, df = 3, p = 0.11. The interaction between age and treatment
effects was not statistically significant (Q(3) = 4.18, p = .24), therefore age did not moderate the
odds of smoking cessation. Percentage of male participants in each study were also divided into
four groups (50-70%, 71-80%, 81-90%, 91-100%). A permutation test indicated there were no
significant differences between percentage of male participants per study,  = 1.41, df = 3, p =
.70. A Kruskal-Wallis rank sum test confirmed this conclusion,  = 1.69, df = 3, p = 0.64;
therefore percentage of males did not moderate the odds of smoking cessation (Q(3) = .9, p =
.83). Ethnicity was divided into five groups (Chinese, Japanese, Korean, Thai, and mixed). A
permutation test indicated there were no significant differences between ethnic groups,  = 2.05,
df = 3, p = 0.56. A Kruskal-Wallis rank sum test confirmed this conclusion,  = 1.74, df = 3, p =
0.63. See Table 2 for characteristics of individual types of treatment.
Table 2
Odds Ratios, Confidence Intervals, and Significance Values by Moderator Variable for Smoking
Cessation Interventions with Asians and Asian Americans
Variable
Total sample
Demographic/Clinical moderators
Male percentage
50-70%
71-80
81-90
91-100%
Age
21-30
31-40

N
28

OR
2.33

CI
(1.77, 3.06)

P
.00

2
2
10
12

1.30
2.25
2.15
2.70

(.50, 3.36)
(1.52, 3.33)
(1.51, 3.06)
(1.57, 4.65)

.60
.00
.00
.00

1
9

2.37
2.30

(.83, 6.76)
(1.56, 3.40)

.12
.00
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Variable
41-50
51-60
Asian ethnicity
Chinese
Korean
Japanese
Thai
Mixed
Theory relevant moderators
Primary treatment type
NRT
Bupropion
Counseling
Physician advice
Varenicline
Health education
Other
Treatment intensity
Low
Moderate
High
Treatment duration
Within a day
Within a week
Within a month
Within 3 months
Within 6 months
Within 12 months
Cultural tailoring
Tailored specifically for AA subgroups
Tailored broadly for AA
Location
United States
Asia
Intervention components
Single
Multiple
Cessation verification
Biochemical
Self-report
Smoking status outcome
24 Hour
7 Day
1 Month
6 Month

29

N
11
4

OR
2.32
1.32

CI
(1.61, 3.35)
(.87, 2.00)

p
.00
.20

15
6
3
1
3

2.81
1.70
1.55
1.78
2.77

(1.77, 4.49)
(1.04, .75)
(.79, 3.03)
(.94, 3.34)
(2.19, 3.50)

.00
.03
.20
.08
.00

2
1
12
2
4
2
5

3.82
3.71
3.34
1.61
2.57
1.17
1.27

(2.08, 7.03)
(1.86, 7.40)
(1.85, 6.04)
(1.10, 2.35)
(2.11, 3.14)
(.58, 2.38)
(.81, 1.10)

.00
.00
.00
.01
.00
.66
.29

3
10
15

1.37
1.49
3.57

(.75, 2.52)
(1.17, 1.89)
(2.42, 5.28)

.31
.00
.00

1
1
4
9
8
2

2.37
1.6
5.25
2.61
2.13
1.24

(.83, 6.76)
(1.04, 2.47)
(.84, 32.83)
(1.91, 2.57)
(1.60, 2.84)
(.50, 3.07)

.11
.03
.08
.00
.00
.64

6
1

1.77
2.37

(.90, 3.48)
(.83, 6.76)

.10
.11

7
21

1.83
2.50

(.99, 3.36)
(.84, 3.40)

.05
.00

9
19

1.41
2.87

(1.03, 1.92)
(2.07, 3.96)

.03
.00

19
8

2.52
1.30

(2.05, 3.10)
(.98, 1.72)

.00
.07

1
10
8
3

2.13
2.03
1.75
3.15

(1.26, 3.59)
(1.45, 2.85)
(1.17, 2.60)
(2.03, 4.90)

.01
.00
.01
.00
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Variable
12 Month

N
1

30
OR
4.94

CI
(1.80, 13.54)

p
.00

Intervention Components
Multi-component interventions are defined as having more than one type of treatment
(e.g., counseling and nicotine replacement therapy). The treatment effect for single component
interventions was OR = 1.41 (95% CI 1.03 to 1.92, p = .03, n = 9). The effect for multicomponent interventions was OR = 2.87 (95% CI 2.07 to 3.96, p = .00, n = 19), indicating a
small to medium effect size. A permutation independence test was conducted to compare
treatment effect between single component and multi-component interventions and found no
significant differences between the two types of treatment, Z = -1.58, p = 0.11. A Wilcox test
also confirmed the result, W = 53, p = 0.12. These results suggest multi-component interventions
are not significantly more effective in treating smoking than single component interventions. The
number of intervention components does not impact odds of smoking cessation (Q(1) = .02, p =
.88).
Cultural Tailoring
Of the 28 studies included, seven studies were conducted in the United States and 21
studies were conducted in Asia. Of the seven U.S. studies, 100% were coded as culturally
tailored. Cultural tailoring is conceptualized as designing or adapting intervention components to
fit a cultural minority population (Pasick et al., 1996). Of the 21 Asian studies, none described
cultural tailoring; therefore, studies conducted in Asia are not assessed as part of the analyses.
Since all U.S. studies were coded as culturally tailored, a comparison of culturally tailored verses
non-culturally tailored studies was not possible; therefore, the hypothesis regarding culturally
tailoring could not be tested. A permutation test comparing U.S. studies that were tailored for
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AAs broadly verses AA subgroups was not significant,  = 0.46, df = 2, p = 0.80. A KruskalWallis rank sum test also supports the above result,  = 0.16, df = 2, p = 0.92. See Table 2 for
ORs associated with each type of cultural tailoring. Furthermore, an independent permutation
test revealed there were no differences between studies that were only linguistically tailored and
studies that included cultural tailoring features in addition to being linguistic tailoring, Z = -0.64,
p = 0.52. A Wilcoxon rank sum test confirms this finding, W = 68, p = 0.92.
Nicotine Dependency
The Fagerstrom Test for Nicotine Dependence was used to assess baseline nicotine
dependency in 15 studies. Scores were rated on a scale from 1 to 4 (1 = low, 2 = low to
moderate, 3 = moderate, 4 = high). A Mann-Whitney U test was conducted to compare the effect
of smoking cessation between low, low to moderate, moderate, and high nicotine dependence. A
non-parametric test was used as there were not enough observations to conduct a one-way
ANOVA. There was not a significant effect of baseline severity of nicotine dependence on
smoking cessation,  = 3.38, df = 2, p = .18.
Treatment Intensity
Treatment intensity was rated on a scale from 1 to 3, where 1 = low intensity (e.g.,
passive receipt of materials, brief phone call, no clinic visit), 2 = moderate intensity (e.g., one
clinic visit, telephone counseling sessions), 3 = high intensity (e.g., multiple clinic visits,
frequent contact with staff, adherence monitoring). A nonparametric one-way between-studies
Kruskal-Wallis was conducted to compare the effect of smoking cessation between low,
moderate, and high intensity interventions. There was a significant effect of treatment intensity
on smoking cessation for the three levels of intensity,  = 9.77, df = 2, p = .01. Post hoc
comparisons using the Tukey and Kramer test indicated that the ORs for the high intensity
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treatment differed significantly from the moderate intensity group (p = .02). The low intensity
treatment was not significantly different than the moderate (p = .95) or high intensity treatment
(p = .09). See Table 2 for ORs associated with each type of intensity. Results suggest treatment
intensity is a moderator, with higher intensity treatments predicting higher odds of smoking
cessation (Q(2) = 10.07, p = .01).
Treatment Duration
Treatment duration varied from each study, ranging from one day to 12 months with 68%
being three to six months long. A permutation test revealed there were not significant differences
between the different durations of treatment,  = 3.71, df = 5, p = 0.59. Results from a KruskalWallis test confirmed this result,  = 3.41, df = 5, p = 0.64. Moderation analyses revealed length
of treatment does not impact the odds of smoking cessation (Q(5) = 4.52, p = .48). Table 2
provides characteristics of the treatment durations.
Other Factors
Hypotheses were made about intention to quit and acculturation predicting smoking
cessation, however, there were not enough studies measuring these two variables to run
moderation analyses. Average ESOR for studies measuring intention to quit was 1.56 (95% CI
0.98 to 2.31, p = .06, n = 4), whereas average ESOR for studies measuring acculturation was 1.69
(95% CI 0.74 to 4.30, p = .2, n = 4), with both indicating a small effect size.
Treatment Type
Primary treatment types included: NRT, bupropion, individual counseling, physician
advice, varenicline, health education, or other. As previously mentioned, for multicomponent
treatments, whatever treatment was stated as primary was coded as such. Table 2 shows ORs
associated with each type of treatment. A permutation test indicated there were no significant
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differences between treatment type,  = 8.27, df = 6, p = .22. The type of treatment did not
moderate the odds of smoking cessation (Q(6) = 8.3, p = .27).
Location of Intervention
The treatment effect for interventions conducted in the United States was OR = 1.83
(95% CI .99 to 3.36, p = .05, n = 7), indicating a small to medium effect size. The treatment
effect for studies conducted in an Asian country (Japan, Thailand, Korea, China) was OR = 2.5
(95% CI 1.84 to 3.4, p = .00, n = 21), indicating a small to medium effect size. An independent
permutation test and Mann Whitney U were conducted to compare treatment
effect between interventions located in the United States and Asian countries. Results revealed
there was not a significant difference between interventions conducted in the United States and
interventions conducted in Asia, Z = -0.63613, p = 0.52 (W = 71, p = 0.91). These results suggest
interventions for AAs are not significantly more effective in Asian countries than the United
States. Location of the treatment did not impact treatment effects (Q(1) = .61, p = .43).
Cessation Verification
The effect size when smoking status was verified biochemically was 2.52 (95% CI 2.05
to 3.10, p = .00, n = 20), indicating a small to medium effect size. When smoking status was not
biochemically verified, the effect size was 1.30 (95% CI 0.98 to 1.72, p = .07, n = 8), indicating a
small effect size. An independent permutation test revealed there was a significant difference
between studies with biochemical verification and studies with only self-report, Z = -2.40, p =
.02. Moderation analyses suggest studies that include a biochemical verification component
predict higher odds of smoking cessation than studies that use self-report (Q(1) = .6.9, p = .01).
Smoking Status Outcome Measure
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Studies differed on the primary outcome measure. The differences between primary
outcome measures were not significant ( = 5.84, df = 4, p = .21.). Smoking status outcomes did
not have an impact on odds of smoking cessation (Q(4) = 5.31, p = .26). See Table 2 for ORs.
Risk Bias
One hundred percent of studies used true randomization for allocation of participants,
therefore eliminating selection bias. Regarding performance bias, only two studies were double
blind experiments, 12 studies were single blind experiments, and 14 studies did not include a
blinding component.
Discussion
The current meta-analysis aimed to examine the effectiveness of smoking cessation
interventions for AAs and different factors that may influence treatment effectiveness. Twentyeight trials of smoking cessation interventions were included, representing outcome data on
17,660 smokers. Results revealed a small to medium effect size (OR = 2.33), indicating smoking
cessation interventions are effective for AAs compared to control, placebo, and waitlist groups.
USDHS’ clinical practice guidelines (Fiore et al., 2008) for treating tobacco dependence
state that there is strong evidence for the effectiveness of cessation interventions for all smokers,
including different racial and ethnic minorities (Baillie et al., 2004; Fiore et al., 2008). Results
from this meta-analysis are consistent with previous research showing that smoking cessation
interventions are effective for the general population. All interventions included in this metaanalysis were found to be more effective than control conditions, except for health education (p =
.66) and “other” types of interventions (p = .29), which included providing health risk appraisals
and genetic feedback on cancer risk. This meta-analysis found a medium to large effect size (OR
= 3.82) for NRT, which is higher than the what previous meta-analyses have found for the

SMOKING CESSATION INTERVENTIONS FOR AAs

35

general population (Etter & Stapleton, 2006; Wu et al., 2006). Regarding bupropion and
varenicline, this study generated a large effect size (OR = 3.71) and a medium effect size (OR =
2.57) respectively, which is also higher than previously found (Wu et al., 2006). This study
generated a medium to large effect size (OR = 3.34) for counseling while other meta-analyses
found small effect sizes, with ORs ranging from 1.20 to 1.64 (Lichtenstein et al., 1996; Mojica et
al., 2004). Overall, these results are consistent with previous research.
The current meta-analysis demonstrates that smoking cessation interventions are effective
for AAs. This is particularly important given that AAs along with Native Americans have the
least representation in clinical trials of smoking cessation interventions (Cox et al., 2011).
Results from this meta-analysis (OR = 2.33, 95% CI = 1.77 to 3.06, n = 28) are comparable to
other meta-analyses evaluating smoking cessation in ethnic/racial minority groups in the U.S.
Webb (2008) conducted a meta-analysis with African Americans which yielded a small effect
size, with an average OR of 1.41 (95% CI 1.16 to 1.73, n = 19). When evaluating smoking
cessation for Hispanics, Webb et al. (2010) found an overall OR of 1.54 (95% CI 1.09 to 2.16, n
= 5), which is a small effect size. This meta-analysis generated a higher OR and wider CIs than
Webb (2008) and Webb et al. (2010). It could be related to all seven U.S. studies being culturally
tailored, compared to just the majority studies of Webb (2008) and Webb et al. (2010) being
culturally tailored, as researchers argue that interventions are more effective when consistent
with a population’s culture (e.g., American Psychological Association, 2003; Baldwin, et al.,
1996; Barrera Jr. et al., 2013; Bernal et al., 2009; Resnicow et al., 2000; Sue et al., 1991; Vega,
1992).
Clinical practice guidelines (Fiore et al., 2008) graded research supporting cultural
tailoring as “C,” indicating “no recommendation for or against” the service (U.S. Preventative
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Services Task Force, 2018). Because all studies conducted in the U.S. were culturally tailored, it
was not possible to the test whether culturally tailored interventions were more effective than
non-culturally tailored interventions. Moreover, the concept of cultural tailoring is researched
within contexts where non-White individuals are minorities (Pasick et al., 1996), thus, the studies
based in Asia did not describe tailoring elements. At the same time, it is reasonable to assume
that intervention elements were specific to that cultural context. Contrary to our hypothesis, we
did not find a significant difference between studies culturally tailored for AA subgroups (n = 6)
and studies culturally tailored for AA broadly (n = 1). A small sample size (n = 7) could explain
the non-significance. Also, cultural tailoring can be widespread, ranging from using culturally
syntonic language, to using correct content like cultural values, knowledge, and traditions, to
considering context, such as acculturative stress (Bernal et al., 1995). Hall et al. (2016) suggest
that some cultural modifications, such as cultural content and values, will more strongly impact
outcomes compared to more minor modifications, such as language translation, as it
encompasses more of the specific cultural characteristics. The majority of studies (n = 4) that
were coded as culturally tailored only had a tailored language component, which is needed for
non-English speaking populations. There were three studies that included more cultural
components, such as using race related statistics and addressing cultural beliefs. Future studies
should compare interventions using surface structure and deep structure cultural tailoring
(Resnicow et al., 2000).
In the current meta-analysis, the majority of interventions were of high treatment
intensity, and treatment intensity moderated treatment effectiveness. These findings support
previous research (Raw et al., 1998). High intensity treatments require more patient engagement,
as it often involves patients visiting the clinic, contacting providers, and actively participating
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(e.g., group therapy, using NRT every day). Patient engagement, defined as patients and
healthcare providers working in active partnerships at various levels across the healthcare
system, has been shown to improve health outcomes and health care (Carman et al., 2013;
Epstein & Street, 2008). A study conducted by Cunningham (2014) found that patients who were
highly engaged were more likely to try to stop smoking than patients who were less engaged.
Patient engagement allows smokers to track their progress, ask questions, and receive extra
support (Carman et al., 2013). Patient engagement can also affect how providers interact with
smokers. If smokers seem engaged and interested, physicians may be more likely to offer
assistance and resources (Carman et al., 2013). In the current meta-analysis, treatment duration
did not have a significant effect on smoking cessation outcomes. It is important to clarify that
longer duration interventions do not equate greater intensity treatments or greater patient
engagement; in fact, two interventions had a duration of 12 months but were coded as low
intensity.
The Society for Research on Nicotine and Tobacco developed recommendations for
outcome assessment, including outcome measures and outcome verification (Benowitz et al.,
2002; Hughes et al., 2003). The recommended primary outcome is prolonged abstinence, defined
as continuous abstinence following a 2-week grace period (Hughes et al., 2003). Secondary
outcomes should be seven- and 30- day point prevalence; six and/or 12 month follow up should
be used to examine long term treatment effects (Hughes et al., 2003). The majority of studies in
this meta-analysis used seven-day point prevalence as the primary outcome whereas one month
(28 days) continuous abstinence was the second most used outcome measure. The measure of
smoking status was not shown to moderate the overall effectiveness of treatment. The odds of
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smoking cessation were higher when 12 month sustained abstinence was the definition of
quitting, however, only one study used this outcome measure.
Biochemical verification, such as expired breath carbon monoxide or cotinine in urine,
plasma, or saliva, is recommended compared to only self-report (Benowitz et al., 2002) due to
possible underreporting (Patrick et al., 1994; Velicer et al., 1992) and bias (Dolcini et al., 1996).
Over half of the studies in this meta-analysis used biochemical verification, specifically expired
breath carbon monoxide. The use of biochemical verification moderated the overall effect of
smoking cessation treatment. Studies that verified smoking status via biochemical verification
had larger effect sizes. Knowledge that smoking cessation would be biologically validated may
serve as an incentive to quit, as there is more accountability than self-report. Participant feedback
on an intervention using biochemical feedback as an intervention component found that
receiving information on smoker and nonsmoker smoke exposure motivated cessation in the
short term (Saw et al., 2018; Tong et al., 2018).
In this study, approximately 88% of participants were male, with five studies including
only males. The overall sample was majority Chinese, older adult, and male, which is
representative of the AA smoking population. Therefore, results implicate that smoking cessation
interventions can improve the odds of cessation for majority AA smokers. Results revealed age
and gender did not have a significant effect on smoking cessation. These results align with
previous literature (Abdullah et al., 2006; Jarvis et al., 2013; Wetter et al., 1995). Although there
were not significant differences, previous research has found that females are less likely to
successfully quit smoking, more likely to relapse after quitting, and more likely to experience
withdrawal symptoms compared to males (Abdullah, et al., 2006; Wetter et al., 1995).
Limitations

SMOKING CESSATION INTERVENTIONS FOR AAs

39

There were several limitations to this meta-analysis that should be noted. First, there was
a limited number of treatment studies (n = 28), therefore the results of this meta-analysis will
need to be updated as more research is conducted. This also affected the moderator analyses, as
there were insufficient observations of each moderator across studies to conduct a
metaregression. Bornstein et al. (2009) recommends moderators being characterized in at least
10 studies, whereas Fu et al. (2010) suggests four observations are needed in each group to run a
moderator analysis. These moderator analyses should be considered preliminary due to the
limited number of studies. Second, although these results are geared towards AAs, these results
are not generalizable to all AAs. AAs are divided into subgroups, each with their own ethnic
ancestry and cultural values. Specifically, this meta-analysis only included Chinese, Japanese,
Korean, and Thai smokers. However, majority of the sample was Chinese, male, and older.
Therefore, these findings may not generalize broadly to the AA population. Additionally, these
findings may not generalize to populations with specific characteristics, such as pregnant
women, adolescents/young adults, or individuals with medical or psychiatric problems. Third,
cultural tailoring was difficult to assess as all studies targeted AA populations and many
interventions were conducted in an Asian country. Additionally, researchers do not always
provide information on cultural responsiveness, making it difficult to detect an effect of cultural
tailoring (Huey & Polo, 2008). It is important for studies to highlight how interventions were
culturally tailored to prevent mis- or underreporting of cultural tailoring. The studies included in
this meta-analysis were all published in English, therefore studies published in another language
with possible meaningful data were not able to be analyzed. Next, the methodological reporting
of some studies made it difficult to extract demographic information. For example, some studies
did not report the gender ratio or length of treatment. Some demographic information was

SMOKING CESSATION INTERVENTIONS FOR AAs

40

reported in different units across studies. For example, FTND scores were reported as
frequencies, percentages, and average scores. Another limitation is that intention to quit was not
assessed as a moderator. Research shows that intention to quit smoking predicts smoking
cessation in the general population (Godin et al., 1992) as well as in subpopulations (Armitage,
2007; Johnston et al., 2004; Norman et al., 1999). The Theory of Planned Behavior also indicates
that intention to perform a behavior, predicts that behavior (Ajzen, 1991). Along with intention
to quit, there are many other factors that are associated with intention to quit and smoking
cessation that were not assessed, such as positive attitudes and perceived behavioral control
(Bennet & Clatworthy,1999; Borland et al., 1991; Hu & Lanese, 1998; Maher & Rickwood,
1997). Use of emerging tobacco products, such as electronic cigarettes, is increasing among
young adults (Dai & Leventhal, 2019), yet, no intervention studies involving these products were
available at the time of review. Lastly, to determine effectiveness, smoking cessation
interventions often compare the intervention group to an active control group (Johnston et al.,
2020). It is possible that the variability of the comparator group impacted findings, as comparator
groups could receive no behavioral support, usual care, or self-help materials. A study conducted
by Johnston et al. (2020) gives support to the idea that researchers need to consider variability in
comparator interventions when interpreting, comparing, and generalizing trial effect sizes.
Implications
These findings have clinical, research, and theoretical implications regarding smoking
cessation in AAs. Clinically, healthcare providers should continue to encourage AAs to use
smoking cessation interventions. Information from this meta-analysis should be incorporated into
existing interventions, as well as considered when developing new interventions to increase the
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odds of smoking cessation among AAs. Theoretically, this information can inform researchers on
treatment methods among AAs.
This meta-analysis paves way for more research in this area. First, more research
comparing culturally tailored and non-culturally tailored interventions is needed to understand
the role of culture with regards to smoking cessation in AAs. More specifically, research should
investigate surface structure (e.g., language, relevant statistics) and deep structure (e.g.,
acculturative stress) components. Additionally, although cultural tailoring is conceptualized as
modifications or adaptations for minority groups, future intervention studies—irrespective of
implementation in a majority or minority culture—should describe key intervention components
that are tailored for their target population. By doing so, others may more readily discern
whether the intervention may be useful for a culturally similar population. Researchers should
also consider using the same units or operational definitions to increase ability to identify and
compare possible moderators. Researchers should also aim to examine cessation interventions
for emerging tobacco products as well as nontraditional intervention methods, such as those with
a technological component (e.g. online interventions, texting interventions, smartphone
applications, etc). As more studies in this area are conducted, this meta-analysis should be
updated with the new information.
Conclusion
To summarize, findings show that overall, smoking cessation interventions are effective
for AAs; therefore, AAs should be encouraged to engage in cessation interventions. However, it
is imperative that more intervention research is conducted with this diverse population. In
particular, increased research attention is needed for currently underresearched high disparity
subpopulations, such as Vietnamese, Filipino, and Indian male smokers. Finally, more research
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examining cultural factors that contribute to use and cessation and testing effectiveness of
culturally tailored interventions would help reduce disparities, and potentially increase smoking
cessation and improve health outcomes both in the short and long term.
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Appendix A
PRISMA Statement
Section/topic
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TITLE
Title

1

Identify the report as a systematic review, meta-analysis, or
both.

2

Provide a structured summary including, as applicable:
background; objectives; data sources; study eligibility criteria,
participants, and interventions; study appraisal and synthesis
methods; results; limitations; conclusions and implications of
key findings; systematic review registration number.

Rationale

3

Describe the rationale for the review in the context of what is
already known.

Objectives

4

Provide an explicit statement of questions being addressed
with reference to participants, interventions, comparisons,
outcomes, and study design (PICOS).

Protocol and
registration

5

Indicate if a review protocol exists, if and where it can be
accessed (e.g., Web address), and, if available, provide
registration information including registration number.

Eligibility criteria

6

Specify study characteristics (e.g., PICOS, length of followup) and report characteristics (e.g., years considered,
language, publication status) used as criteria for eligibility,
giving rationale.

Information
sources

7

Describe all information sources (e.g., databases with dates
of coverage, contact with study authors to identify additional
studies) in the search and date last searched.

Search

8

Present full electronic search strategy for at least one
database, including any limits used, such that it could be
repeated.

Study selection

9

State the process for selecting studies (i.e., screening,
eligibility, included in systematic review, and, if applicable,
included in the meta-analysis).

Data collection
process

10

Describe method of data extraction from reports (e.g., piloted
forms, independently, in duplicate) and any processes for
obtaining and confirming data from investigators.

Data items

11

List and define all variables for which data were sought (e.g.,
PICOS, funding sources) and any assumptions and
simplifications made.

Risk of bias in
individual studies

12

Describe methods used for assessing risk of bias of individual
studies (including specification of whether this was done at
the study or outcome level), and how this information is to be

ABSTRACT
Structured
summary

INTRODUCTION

METHODS

Reported
on page #
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used in any data synthesis.
Summary
measures

13

State the principal summary measures (e.g., risk ratio,
difference in means).

Synthesis of
results

14

Describe the methods of handling data and combining results
of studies, if done, including measures of consistency (e.g., I2)
for each meta-analysis.
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Search Terms
Searches will be conducted using a combination of these key search terms
1. Asian
3. Asian American
5. Pacific Islander
7. Vietnamese
9. Vietnamese American
11. Chinese
13. Chinese American
15. Korean
17. Korean American
19. Japanese
21. Japanese American
23. Filipino
25. Filipino American
27. Indian
29. Indian American
31. Cambodian
33. Cambodian American
35. Thai
37. Thai American
39. Laotian
41. Laotian American
43. Tahitians
45. Maori
47. Fijians

2. Native Hawaiian
4. Hawaiian
6. Tongan
8. Chamorran
10. Samoan
12. Polynesian
14. Micronesian
16. Melanesian
18. South Asian
20. Southeast Asian
22. East Asian
24. Asian immigrants
26. Smoking
28. Tobacco
30. Tobacco dependence
32. Cigarettes
34. Tobacco intervention
36. Tobacco cessation
38. Smoking cessation
40. Smoking intervention
42. Tobacco programs
44. Smoking dependence
46. Smoking programs
48. Nicotine dependence
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Appendix C
Data Screening and Extraction Form
Study ID:

Study Title:

Year of study:

Date of screening:

Person who screened:

Date of data extraction:
Person who extracted data:

Citation:

1. General Information
Publication type: Journal Article  Book chapter  Other (specify e.g., manual) ____________________
Country of study:

Language of the article:

2. Study Eligibility
Study Characteristics (Even if a study does not meet the inclusion criteria, all study characteristics
still need to be documented)

Aim of study

To examine or evaluate an intervention that aims to reduce
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Participants

Does the study primarily target Asian and/or Asian American
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Does the study include a sample of adult (18+) Asian and/or
Asian American smokers?

 Yes
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 Unclear
 Yes
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Does the study include a specific sample (e.g., medical issues,
pregnancies)?

 Unclear
Sample size

If the study targets Asian and/or Asian American smokers,
what is the sample size (for Asian/Asian Americans only)?

Sample size:
____________

Does the study include non-Asian sample? If yes, what is the
non-Asian sample size?

Sample size:

What is the total (both Asian and non-Asian) sample size of
the study?

Total Sample:

____________
_____________

Page/
Para/
Figure
#
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Type of study  Original, peer reviewed and empirical articles
 Dissertation/Thesis
 Intervention protocols

 Yes
 No →Exclude
 Unclear

 Intervention pilot/feasibility studies
 Intervention evaluation studies
-

 Randomized Controlled Trial (RCT)
 Cluster Randomized Controlled Trial (cluster RCT)
 Pre-post single group comparison
 Others: ___________________________________

 Systematic review/meta-analyses
No →Exclude
 Non-peer reviewed articles
 Others: _________________________________________
Methodology

Does the study provide quantitative outcomes?

 Yes
 No →Exclude
 Unclear

Does the study compare against a control group?

 Yes
 No →Exclude
 Unclear

Language

Is the article written in English?

 Yes
 No →Exclude

Intervention
description

Does the study include a description of the intervention
studied or tested?

 Yes
 No →Email
author
 Unclear

Summary of Assessment for Inclusion
Include in review 

Exclude from review 

Independently assessed, and then compared? Yes  No 
Request further details?

Yes  No 

Differences resolved

Yes  No 

Contact details of authors: (if further details
needed)

Notes: (i.e. What details are missing?)
DO NOT PROCEED IF PAPER EXCLUDED FROM REVIEW
3. Intervention details (*If the article mentions more than 1 intervention, for example an RCT,
then we will code each of the intervention, including the treatment-as usual group)
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Dimensions

Descriptions as stated in the report/paper

Name of
intervention
(if applicable)
Aim of
intervention

What was the name of the intervention?

Aim of study

What was the study designed to assess? Are these clearly stated?

# of groups

How many groups were there (control and intervention)?

Total study
duration
Setting

What was the problem that this intervention was designed to address?

Where did the intervention take place? (e.g., academic medical center,
university teaching hospitals, rural, metropolitan, school, workplace,
community, GP clinic)

Providers

Who were the providers? (e.g., number, profession, education/training,
ethnicity)

Participants

Where were participants recruited from?
Mean/range of participants’ age: ______________________________
Gender composition of participants sample:
Males (n):_______ Females (n):________
Males (%):_______ Females (%):________
Number of participants sample:
Asian/Asian American: (n):_________ (%):__________
Non-Asian (if any): (n):_________ (%):_____________
Ethnicity breakdown (n):______________ (%):___________
Other participants’ characteristics: (e.g., US born vs. Foreign born, English
proficiency, SES)

Study numbers Eligible for inclusion: ___________
Excluded: __________
Refused to take part: _________
Randomized to intervention group(s): __________
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Randomized to control group(s): ____________
Excluded post randomization (for each group; with reasons if relevant):
__________
Withdrawn (for each group; with reasons if relevant): __________
Lost to follow up (for each group; with reasons): ____________
Included in the analysis (for each group; for each outcome:
How often did the intervention take place?
How long did the intervention last?
If there were follow-up sessions/activities post interventions, what were they and
how long did they last?
Intervention
types

Delivery

 Health education
 Counseling
- Individual
- Group
- Family
 Multicomponent Intervention (Check all that apply)
 Social support/mutual support/peer support groups
 Consultation/physician advice
 Pharmacological (Check all that apply)
- Buproprion
- Clonodine
- Nortiptyline
- Nicotine Replacement Therapy (NRT)
- NRT: patches
- NRT: gum
- NRT: nasal spray
- NRT: inhaler
- NRT: lozenges
- NRT: Varenicline
 Self-help material (i.e. brochures, pamphlets, books, videos)
 Quitline
 Community outreach
 Others: ______________________________________________________
How was the intervention delivered? (Check all that apply)
 Face-to-face (i.e. classes, workshops, small groups)
 Telephone
 Website
 Mobile apps
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Frequency

 Media (i.e. radio, TV, pamphlet)
 Others: ___________________________________________________
How was the intervention structured? (Check all that apply)
 One-on-one
 In groups
 Smokers-only
 Nonsmoker-only
 Smoker and nonsmoker dyads
 Family as a whole
How often did the intervention take place?

Duration

How long did the intervention last?

Structure

How long was each session?
Intensity

What was the level of treatment intensity? Consider session length, total amount
of contact time, and number of sessions.
 Low (e.g., brief phone call, no clinic visits, passive receipt of materials)
 Moderate (e.g., one clinic visit, telephone counseling sessions)
 High (e.g., multiple clinic visits, frequent contact with staff, adherence
monitoring)

Follow up

If there were follow-up sessions/activities post interventions, what were they and
how long did they last?

Cultural
adaptations (if
applicable)

Was there cultural tailoring to the intervention?
Yes  No  Unclear 
How was the intervention culturally tailored?
 Tailored to Asian Americans broadly
 Tailored specifically to Asian American subgroups
 Tailored broadly for ethnic/cultural minorities

Unit of
Analysis

What was the unit of analysis?
 Individual
 Group
 Community
How was smoking abstinence measured?
 Self-report
 Biochemical verification
- Saliva cotinine
- Breath carbon monoxide
 Both
 Other: __________________

Outcome

What self-reported smoking abstinence outcome was used?
 Day of (no smoking at time of assessment/interview)
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Risk of Bias
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 24-hour point prevalence (no smoking in the past 24 hours)
 7-day point prevalence (no smoking in the past 7 days)
 1 month continuous abstinence (no smoking in the past 28 days)
 6 month sustained abstinence (no smoking in the past 6 months)
 12 month sustained abstinence (no smoking in the past 12 months)
 5-year sustained abstinence (no smoking in the past 5 years)
 Other: _________
What was the average duration of abstinence (in weeks): ________
Selection bias:
Was there true randomization?
 Yes
 No
 Unclear
Was the intervention standardized?
 Yes
 No
 Unclear
Performance bias:
Were intervention conditions known to:
 No one
 Participants
 Providers
 Data collectors
 Others
Detection bias: Was there blinding of outcome assessment?
 Yes
 No
 Unclear
Attrition bias:
Did they study explain participant attrition and exclusion from analyses?
 Yes
 No
 Unclear
Reporting bias:
How was smoking abstinence measured?
 Self-report
 Biochemical verification
- Saliva cotinine
- Breath carbon monoxide
 Both
 Other: ____________________

4. Data and results
Odds ratio
Intervention (n)

Control (n)
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Quit (n)
Not Quit (n)
Odds ratio: ________

>1  (intervention)

Dichotomous variables
Outcomes
Timing of outcome
measured
assessment
(days/months)
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0  (no relationship)

Intervention group*
Observed
(n)

Total (N)

*add additional columns if there is more than one intervention group
Continuous variables
Outcomes
Timing of outcome
Intervention group
measured
assessment
(days/months)
Mean/Mean Standard
change
deviation

<1  (control)

Comparison group or
Control group (if any)
Observed Total (N)
(n)

Notes

Comparison group or
Control group (if any)
Mean/Me Standard
an change deviation

Notes

Summary of Data Extraction
Completed data extraction 

Request further details? Yes  No 

Verified by second coder? Yes  No 

Second coder: _________________________

Verification completed on: _________________________

Differences resolved Yes  No 

Notes:

